Dr. Esen Akpek Discusses Dry Eye, Sjögren Disease, and Treatment Escalation

Renowned ophthalmologist Dr. Esen Akpek recently shed light on the challenges faced by patients suffering from dry eye disease and Sjögren syndrome, emphasizing the importance of quality of life assessments and timely treatment adjustments.

Understanding Dry Eye Disease and Its Impact

Dry eye disease is a common condition that can significantly affect patients' daily lives. Dr. Akpek points out that the symptoms, which range from mild irritation to severe discomfort, often lead to a decrease in productivity and quality of life. The condition can be exacerbated by environmental factors and prolonged screen time, making it a growing concern in modern society.

Dr. Akpek emphasizes that understanding the nuances of dry eye disease is crucial for effective management. She advocates for comprehensive evaluations, including patient-reported outcomes, to fully grasp the impact on individuals. This approach helps tailor treatment plans that address both the physical symptoms and the emotional toll on patients.

Addressing Sjögren Syndrome

Sjögren syndrome, an autoimmune disease that often accompanies dry eye, presents additional challenges. It can cause severe dryness in multiple parts of the body, including the eyes, mouth, and skin. Dr. Akpek highlights the need for a multidisciplinary approach in managing Sjögren syndrome, given its systemic nature.

According to Dr. Akpek, early diagnosis and intervention are key. Patients with Sjögren syndrome require a personalized treatment plan that not only focuses on alleviating dry eye symptoms but also addresses other manifestations of the disease. Collaboration between rheumatologists, ophthalmologists, and other specialists is essential for comprehensive care.

When to Escalate Treatment

Determining when to escalate treatment is a critical aspect of managing both dry eye disease and Sjögren syndrome. Dr. Akpek advises that clinicians should consider escalation when patients do not respond to initial therapies, or when their quality of life continues to be significantly impacted.

She suggests a stepwise approach, starting with over-the-counter artificial tears and progressing to prescription medications or procedures as needed. For Sjögren syndrome, systemic treatments may be necessary to control the autoimmune response. Dr. Akpek underscores the importance of regular follow-ups to assess treatment efficacy and make timely adjustments.

Dr. Akpek's insights provide valuable guidance for healthcare professionals in optimizing care for patients with dry eye disease and Sjögren syndrome. Her emphasis on individualized treatment plans and collaboration among specialists underscores the complexity of these conditions and the need for a holistic approach to patient care.